First, a semaglutide-only group at the low dose (0.3 mg/kg) was not included, which limits the ability to fully attribute synergistic effects of the combination treatment
Caffeine is protective in patients with non-alcoholic fatty liver disease
This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidates and jeopardize our ability to commercialize our product candidates, if approved, and generate revenue
Evidence shows that semaglutide can help lower the risk of heart disease possibly through its beneficial effects on obesity, blood sugar, and blood pressure: Wegovy, Ozempic, and Rybelsus are all medications that contain the active ingredient semaglutide, but they have different approved uses and formulations